Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/eurheartj/ehz583 | DOI Listing |
JACC Clin Electrophysiol
March 2021
Department of Cardiology, Alfred Hospital, Melbourne, Australia; Department of Cardiology, Baker Heart and Diabetes Institute, Melbourne, Australia; Department of Cardiology, University of Melbourne, Melbourne, Australia; Department of Cardiology, Monash University, Melbourne, Australia.
Resuscitation
April 2020
University of Alberta, Pediatric Critical Care Medicine, Rm 4-539 (ECHA), 11405 87 Ave, Edmonton, AB T6G1C9, Canada; Stollery Children's Hospital, Pediatrics, Rm 4-539 (ECHA), 11405 87 Ave, Edmonton, AB T6G1C9, Canada. Electronic address:
Eur Heart J
September 2019
Cardiac Primary Prevention Research Center (CPPRC), Tehran Heart Center, Tehran University of Medical Sciences, West Jamali Alley, Vafamanesh St, Heravi Sq., Tehran, Iran.
Curr Cardiol Rev
November 2014
ECG Laboratory, 6th floor, Milstein Pavilion, The New York Presbyterian Hospital, 177 Fort Washington Ave., New York, NY 10032, USA.
Advances in the therapy of atrial fibrillation (AF) have not come easily or quickly, despite the recognized need for significantly better antiarrhythmic agents for AF termination and prevention as well as for more user-friendly anticoagulants for the prevention of emboli in patients with AF. Rather, the road has been only slowly progressive and bumpy. This manuscript will introduce the recent issues with dronedarone, the complex development story for vernakalant, and the appearance of the new oral anticoagulants.
View Article and Find Full Text PDFHeart Rhythm
August 2011
Tel-Aviv Sourasky Medical Center and Sackler-School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!